chr9-136673534-T-TCGAGCC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_006412.4(AGPAT2):c.*217_*218insGGCTCG variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0905 in 442,506 control chromosomes in the GnomAD database, including 2,305 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.082 ( 682 hom., cov: 32)
Exomes 𝑓: 0.095 ( 1623 hom. )
Consequence
AGPAT2
NM_006412.4 3_prime_UTR
NM_006412.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.0960
Genes affected
AGPAT2 (HGNC:325): (1-acylglycerol-3-phosphate O-acyltransferase 2) This gene encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. The protein is located within the endoplasmic reticulum membrane and converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. Mutations in this gene have been associated with congenital generalized lipodystrophy (CGL), or Berardinelli-Seip syndrome, a disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-136673534-T-TCGAGCC is Benign according to our data. Variant chr9-136673534-T-TCGAGCC is described in ClinVar as [Likely_benign]. Clinvar id is 365909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.113 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGPAT2 | NM_006412.4 | c.*217_*218insGGCTCG | 3_prime_UTR_variant | 6/6 | ENST00000371696.7 | NP_006403.2 | ||
AGPAT2 | NM_001012727.2 | c.*217_*218insGGCTCG | 3_prime_UTR_variant | 5/5 | NP_001012745.1 | |||
AGPAT2 | XM_047422636.1 | c.*217_*218insGGCTCG | 3_prime_UTR_variant | 6/6 | XP_047278592.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGPAT2 | ENST00000371696.7 | c.*217_*218insGGCTCG | 3_prime_UTR_variant | 6/6 | 1 | NM_006412.4 | ENSP00000360761 | P1 | ||
AGPAT2 | ENST00000371694.7 | c.*217_*218insGGCTCG | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000360759 |
Frequencies
GnomAD3 genomes AF: 0.0822 AC: 12506AN: 152104Hom.: 682 Cov.: 32
GnomAD3 genomes
AF:
AC:
12506
AN:
152104
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0949 AC: 27560AN: 290284Hom.: 1623 Cov.: 5 AF XY: 0.0958 AC XY: 14218AN XY: 148410
GnomAD4 exome
AF:
AC:
27560
AN:
290284
Hom.:
Cov.:
5
AF XY:
AC XY:
14218
AN XY:
148410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0822 AC: 12507AN: 152222Hom.: 682 Cov.: 32 AF XY: 0.0804 AC XY: 5981AN XY: 74390
GnomAD4 genome
AF:
AC:
12507
AN:
152222
Hom.:
Cov.:
32
AF XY:
AC XY:
5981
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
81
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Congenital generalized lipodystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at